Skip to main content

Table 2 The electrocardiographic parameters

From: The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats

 

WKY (n = 9)

SHR (n = 7)

EMPA (n = 7)

P value (ANOVA)

RR (ms)

201.6 ± 26.5

178.7 ± 18.6

193.8 ± 20.4

0.1862

P width (μs)

20.1 ± 1.24

20.8 ± 0.43

19.6 ± 1.7

0.2930

PR (μs)

54.3 ± 4.5

60.3 ± 3.0

59.2 ± 6.4

0.0710

QRS (μs)

30.2 ± 2.3

34.3 ± 5.1

34.5 ± 5.2

0.0923

QT (μs)

109.4 ± 27.0

91.7 ± 7.9

98.3 ± 8.4

0.2028

QTc (μs)

161.2 ± 20.3

154.6 ± 12.2

152.7 ± 9.4

0.5212

  1. Data are presented as mean ± standard deviation
  2. With Tukey’s multiple comparison test
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840